HIM
INSP icon

Hillsdale Investment Management’s Inspire Medical Systems INSP Stock Holding History

Hillsdale Investment Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,325
Closed -$3.04M – 605
2023
Q3 		$3.04M Sell
15,325
-10
-0.1% -$2.52K 0.28% 141
2023
Q2 		$4.98M Sell
15,335
-5,090
-25% -$1.45M 0.46% 56
2023
Q1 		$4.78M Buy
20,425
+18,025
+751% +$4.56M 0.41% 86
2022
Q4 		$605K Sell
2,400
-400
-14% -$85.3K 0.05% 280
2022
Q3 		$497K Hold
2,800
– – 0.04% 326
2022
Q2 		$511K Sell
2,800
-300
-10% -$59.8K 0.04% 335
2022
Q1 		$796K Sell
3,100
-600
-16% -$137K 0.05% 281
2021
Q4 		$851K Sell
3,700
-300
-8% -$73.2K 0.06% 274
2021
Q3 		$932K Sell
4,000
-800
-17% -$167K 0.07% 263
2021
Q2 		$928K Buy
4,800
+700
+17% +$139K 0.07% 276
2021
Q1 		$849K Buy
+4,100
New +$871K 0.07% 272

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Hillsdale Investment Management's INSP Position: Q4 2023 in Review

Hillsdale Investment Management sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 15,325 shares — an estimated $3.04M sold.

Hillsdale Investment Management first reported a position in INSP in Q1 2021 and held it in 11 quarters. The position peaked at $4.98M in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Hillsdale Investment Management reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
  • Hillsdale Investment Management sold 15,325 Inspire Medical Systems shares in Q4 2023, an estimated $3.04M.
  • Hillsdale Investment Management first reported a position in Inspire Medical Systems in Q1 2021 and held it in 11 quarters.
  • Hillsdale Investment Management's Inspire Medical Systems position peaked at $4.98M in Q2 2023.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Hillsdale Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.